Cited by 23Pregnancy and preeclampsia studiesBirth, Development, and HealthNeurological Complications and Syndromes

Decreased very-low-density lipoprotein and low-density lipoprotein receptor messenger ribonucleic acid expression in placentas from preeclamptic pregnancies

Murata, Masanori, Kodama, Hideya, Goto, Kaoru, Hirano, Hideto, Tanaka, Toshinobu·1996·American Journal of Obstetrics and Gynecology

Abstract

Objective Our purpose was to investigate the levels of very-low-density lipoprotein and low-density lipoprotein receptor messenger ribonucleic acid expression in placentas obtained from normal pregnant women at various gestational stages and from patients with preeclampsia.Study design The relative level of expression of very-low-density lipoprotein and low-density lipoprotein receptor messenger ribonucleic acid in each sample was determined by Northern blot analysis as a ratio of the intensity to that of glyceraldehyde-3-phosphate dehydrogenase messenger ribonucleic acid.Results The expression of very-low-density lipoprotein receptor messenger ribonucleic acid increased significantly (p < 0.05) from both the first (n = 9) and second (n = 8) trimesters to the third (n = 11) trimester. Similarly, the expression of low-density lipoprotein receptor messenger ribonucleic acid increased significantly (p < 0.05) from the first to the third trimester. The expression of both very-low-density lipoprotein and low-density lipoprotein receptor messenger ribonucleic acids in third-trimester placentas from preeclamptic pregnancies (n = 13) was significantly lower than that in normal pregnancies in the third trimester.Conclusion These results demonstrate the expression of very-low-density lipoprotein and low-density lipoprotein receptor messenger ribonucleic acids in the human placenta, both of which increase at late gestational stages, and the decreased expression in cases of preeclampsia. Abnormal fetomaternal lipid metabolism resulting from low expression of these receptors in the placenta may be involved in the pathogenesis of preeclampsia.

Integrity signals

Registry

Crossref · 10.1016/s0002-9378(96)70105-9

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Expression of the mRNAs encoding the VLDL-R and LDL-R increases across gestation, but is suppressed at term in pregnancies complicated by pre-eclampsia and severe growth restriction.

    “Expression of the mRNAs encoding the VLDL-R and LDL-R increases across gestation (402, 580), but is suppressed at term in pregnancies complicated by pre-eclampsia and severe growth restriction (402, 552).”

    From Placental Origins of Chronic Disease (2016) · cites this paper as [402]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Murata, M., Kodama, H., Goto, K., Hirano, H., & Tanaka, T.
Affiliations
Akita University (JP)
Venue
American Journal of Obstetrics and Gynecology
Publisher
Elsevier BV
Published
1996-12
Volume
175
Issue
6
Pages
1551-1556
ISSN
0002-9378 (ISSN-L)
OpenAlex
W1971670165
Cited by
23
References
27
Citations by year
2025: 1 · 2022: 1 · 2020: 1 · 2018: 2 · 2016: 2 · 2014: 1 · 2012: 1
FWCI
2.80
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Obstetrics and Gynecology (publishedVersion)
  • PubMed (publishedVersion)
Funders
Ministry of Education, Culture, Sports, Science and Technology
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
  • Health Sciences › Medicine › Psychiatry and Mental health › Neurological Complications and Syndromes
Keywords
preeclampsia, VLDLR, LDL receptor, placenta, mRNA expression, gestational age, lipoprotein metabolism, preeclampsia pathogenesis
MeSH terms
Adult, Female, Humans, Placenta, Pre-Eclampsia, Pregnancy, Pregnancy Trimester, First, Pregnancy Trimester, Second, Pregnancy Trimester, Third, Receptors, LDL, Reference Values, RNA, Messenger, Blotting, Northern

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review